Target
Interleukin-23 (IL-23)
3 abstracts
Abstract
Randomized clinical trial of infliximab versus vedolizumab for immune checkpoint inhibitor related colitis.Org: The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX,
Abstract
Dynamics of circulating cytokines and chemokines during and after tumor-infiltrating lymphocyte cell therapy with lifileucel in advanced melanoma patients.Org: Iovance Biotherapeutics, H. Lee Moffitt Cancer Center and Research Institute, UPMC Hillman Cancer Center, The Royal Marsden Hospital NHS Foundation Trust, Perlmutter Cancer Center, NYU Langone Health,
Abstract
A randomized, open-label, phase II study of high-dose interleukin 2 vs high-dose interleukin 2 plus entinostat in renal cell carcinoma.Org: University at Buffalo Jacobs School of Medicine and Biomedical Sciences, USC Norris Comprehensive Cancer Center, Keck Medicine of USC, Nebraska Cancer Specialists - Midwest Cancer Center, Rush University Medical Center,